Relation Between Interleukin-6, Interleukin-10 And Interleukin-2 Receptor And Mortality In Severely Ill COVID-19 Patients
To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and...
Saved in:
Published in | Journal of the Pakistan Medical Association Vol. 73(Suppl 4); no. 4; pp. S179 - S183 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Pakistan
Pakistan Medical Association
01.04.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection.
This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25.
Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05).
Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients. |
---|---|
AbstractList | To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection.
This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25.
Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05).
Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients. Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. Methods: This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25 Results: Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysis identified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). Conclusion: Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients. Keywords: Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins ObjectivesTo investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection. MethodThis single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25. RESULTSOf the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysisidentified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatory and coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05). CONCLUSIONSElevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients. Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus disease-2019 infection.Methods: This single-centre cohort study was conducted at the Kafrelshiekh University Hospital, Egypt, from January to June 2022, and included all patients of either gender who were hospitalised with severe infection with the coronavirus disease-2019 isolation ward. Chemiluminescence immunoassay method was used to measure levels of procalcitonin, ferritin, soluble interleukin-2 receptor, interleukin-6 and interleukin-10. Data was analysed using SPSS version. 25Results: Of the 250 patients with median age 57.5 years (interquartile range: 45.8-66.0 years), 147(59%) were males and 103(41%) were females. Of them, 102(40.8%) patients died; 68(66.7%) males, 34(33.3%) females, median age 60.0 years (interquartile range: 48.8-70.0). Among the 148(59.2%) survivors, 79(53.4%) were males and 69(46.6%) were females, while the overall median age was 55.0 years (interquartile range: 41.5-65.8 years). The survivors had significantly lower levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 (p<0.001). Correlation analysis identified significant positive correlation between IL-2R, IL-6 and IL-10 levels and almost all the inflammatoryand coagulation parameters, including C-reactive protein, lactate dehydrogenase, procalcitonin, ferritin, D-dimer and fibrinogen (p<0.05).Conclusion: Elevated levels of soluble interleukin-2 receptor, interleukin-6 and interleukin-10 were found to be associated with greater risk of mortality in coronavirus disease-2019 patients.Keywords: Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins |
Author | Sherif, Dalia Elsayed Hassan, Asmaa Embarak Nosair, Nahla Abdelaziz Habib, Eman Mohammad Farahat, Nahla Ahmed, Mohammed Hussien |
Author_xml | – sequence: 1 givenname: Asmaa Embarak surname: Hassan fullname: Hassan, Asmaa Embarak organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt – sequence: 2 givenname: Nahla Abdelaziz surname: Nosair fullname: Nosair, Nahla Abdelaziz organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt – sequence: 3 givenname: Mohammed Hussien surname: Ahmed fullname: Ahmed, Mohammed Hussien organization: Department of Internal Medicineand Gastroenterology, Kafrelsheikh University,Egypt – sequence: 4 givenname: Dalia Elsayed surname: Sherif fullname: Sherif, Dalia Elsayed organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt – sequence: 5 givenname: Eman Mohammad surname: Habib fullname: Habib, Eman Mohammad organization: Department of Clinical Pathology, Kafrelsheikh University,Egypt – sequence: 6 givenname: Nahla surname: Farahat fullname: Farahat, Nahla organization: Department of Clinical Pathology, Alexandria University, Alexandria,Egypt |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37482854$$D View this record in MEDLINE/PubMed |
BookMark | eNpVUU1PGzEQ9YGKr3LurdpjD13w966PacpHEAhE2ko9Wd71GC04dmo7oPx7loQicZqZN2_ek-YdoJ0QAyD0heBj3jBFTi5vryfHp-d_6zmvmdxB-xgzXCvV0j10kPMDxlQKjHfRHmt4S1vB99H6DrwpQwzVDyjPAKGahQLJw-pxCLX8_mEkuJoE-wGi1R30sCwxbVbXMRXjh7IeSdUcniCBH3vvq-nNn9nPmqjqdrSDUPJn9MkZn-HorR6i32env6YX9dXN-Ww6uap7JlmpDZMWrOtBOWaFwYD71incSGVF04CVje065YwVinXgeNNTKZWwSmFMKLPsEM22ujaaB71Mw8KktY5m0BsgpnttUhl6D5oqSnhHO2Gs5I4SJUYXx5kZXyU6Tkatb1utZYr_VpCLXgy5B-9NgLjKmraccEyZkiP1ZEvtU8w5gXu3Jlhv8tKveekxLz3nmr1efH0TX3ULsO_8_2GxFzwflCE |
CitedBy_id | crossref_primary_10_58742_bmj_v2i2_96 |
ContentType | Journal Article |
DBID | NPM AAYXX CITATION 7X8 DOA |
DOI | 10.47391/JPMA.EGY-S4-36 |
DatabaseName | PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EndPage | S183 |
ExternalDocumentID | oai_doaj_org_article_29214b2b5ad64f219569df43a8545b41 10_47391_JPMA_EGY_S4_36 37482854 |
Genre | Journal Article |
GroupedDBID | --- .55 0ZK 2WC 53G 5GY ABCQX ABUBX ACGFO ACMJI ADCHZ ADEYR AEGXH AENEX AFJDA AGFXM AGQRV AHEHV AHHXF AHKOF AIAGR AKNUK ALMA_UNASSIGNED_HOLDINGS BAI BAW DIK E3Z EBD EMOBN EOJEC F5P FRP GROUPED_DOAJ GX1 IAO IEA IHR IHW INH INR ITC L7B LGEZI LOTEE LXO MK0 MV. NADUK NFBOU NKUNM NPM NXXTH NYMDV OBODZ OK1 P2P PV9 RXW RZL SV3 TAA TUS UNMZH USXSC W2D X7M ~ZZ AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c363t-a36dedfce9f3d5a0e0c8f90769d577ed67dbb9fad593bef47c26695d9900123d3 |
IEDL.DBID | DOA |
ISSN | 0030-9982 |
IngestDate | Tue Oct 22 15:15:18 EDT 2024 Fri Oct 25 01:54:25 EDT 2024 Fri Aug 23 02:54:58 EDT 2024 Wed Oct 16 00:38:45 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 4 |
Keywords | Interleukin-6, Interleukin-10, Procalcitonin, Fibrin fragment D, COVID-19, Luminescence, Interleukin-2, Immunoassay, Fibrinogen, Ferritins |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c363t-a36dedfce9f3d5a0e0c8f90769d577ed67dbb9fad593bef47c26695d9900123d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doaj.org/article/29214b2b5ad64f219569df43a8545b41 |
PMID | 37482854 |
PQID | 2841402396 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_29214b2b5ad64f219569df43a8545b41 proquest_miscellaneous_2841402396 crossref_primary_10_47391_JPMA_EGY_S4_36 pubmed_primary_37482854 |
PublicationCentury | 2000 |
PublicationDate | 2023-04-01 |
PublicationDateYYYYMMDD | 2023-04-01 |
PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Pakistan |
PublicationPlace_xml | – name: Pakistan |
PublicationTitle | Journal of the Pakistan Medical Association |
PublicationTitleAlternate | J Pak Med Assoc |
PublicationYear | 2023 |
Publisher | Pakistan Medical Association |
Publisher_xml | – name: Pakistan Medical Association |
SSID | ssj0026500 |
Score | 2.3362918 |
Snippet | To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe coronavirus... Objective: To investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe... ObjectivesTo investigate the relation involving soluble interleukin-2 receptor, interleukin-6 and interleukin-10 in hospitalised patients with severe... |
SourceID | doaj proquest crossref pubmed |
SourceType | Open Website Aggregation Database Index Database |
StartPage | S179 |
SubjectTerms | COVID-19 Fibrin fragment D Interleukin-10 Interleukin-6 Luminescence Procalcitonin |
Title | Relation Between Interleukin-6, Interleukin-10 And Interleukin-2 Receptor And Mortality In Severely Ill COVID-19 Patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37482854 https://search.proquest.com/docview/2841402396 https://doaj.org/article/29214b2b5ad64f219569df43a8545b41 |
Volume | 73(Suppl 4) |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsQwFA3iQtyIb8cXEVy4MNo2aTJZ-n7AqDAq4yokzS0MjlV0ZuHfe5N2fCzEjZtCm0LCzS3nnObmhJBtKxzOq-TMqgyYUBaYRSLBpLSIfpAAh7B3uHMlz-_EZS_vfTvqK9SE1fbAdeD2M52lwmUut16KMgvb27QvBbdtxH4nauGT6LGYaqQW8o7GkDFhKCiy2tRHKK7T_cubzsHeydkD6woWnZm_8Cja9v_ONSPmnM6SmYYs0oN6kHNkAqp5MtVplsMXyPu4lI025VY0_uAbwOixXzG5--M2Tait_I9HGUXWCC8ou2PTU6TiSMtpv6JdwCSHwTu9GAzo0fX9xTFLNW1sWN8Wyd3pye3ROWvOUmAFl3zILJcefFmALrnPbQJJ0S5RGGMwc6XAS-Wd06X1ueYOSqEKRG6dewSrwLo8XyKT1XMFK4TaBJuD0x8HL6TVzrWVT3OVgi504ZIW2RlH1LzUlhkGpUYMvgnBNxh80xWGyxY5DBH_fC14XccHmAGmyQDzVwa0yNZ4vgx-G2HBw1bwPHozCL2oHzOusaPleiI_uwq2O2H36Op_DGGNTIdj6OuKnnUyOXwdwQaSlaHbjHmJ17Ne-gGYXeR5 |
link.rule.ids | 315,783,787,867,2109,27936,27937 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relation+between+Interleukin-6%2C+Interleukin-10+and+Interleukin-2+Receptor+and+mortality+in+Severely+Ill+COVID-19+patients&rft.jtitle=Journal+of+the+Pakistan+Medical+Association&rft.au=Asmaa+Embarak+Hassan&rft.au=Nahla+Abdelaziz+Nosair&rft.au=Mohammed+Hussien+Ahmed&rft.au=Dalia+Elsayed+Sherif&rft.date=2023-04-01&rft.issn=0030-9982&rft.volume=73&rft.issue=4&rft.spage=S179&rft.epage=S183&rft_id=info:doi/10.47391%2FJPMA.EGY-S4-36&rft.externalDBID=n%2Fa&rft.externalDocID=10_47391_JPMA_EGY_S4_36 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0030-9982&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0030-9982&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0030-9982&client=summon |